Lv66
1850 积分 2024-02-08 加入
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
13分钟前
已完结
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study
3小时前
已完结
RITUXIMAB AND IBRUTINIB COMBINATION IS SAFE AND EFFECTIVE IN UNTREATED SPLENIC AND NODAL MARGINAL ZONE LYMPHOMAS: PLANNED SUBSET ANALYSIS OF THE IELSG47/MALIBU PHASE II STUDY
3小时前
已完结
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma
4个月前
已完结
Analysis of chromosomal copy number changes and oncoprotein expression in primary central nervous system lymphomas: frequent loss of chromosome arm 6q
4个月前
已完结
Comprehensive Assessment of ERα, PR, Ki67, P53 to Predict the Risk of Lymph Node Metastasis in Low-Risk Endometrial Cancer
4个月前
已完结
Redefining aberrant P53 expression of gastric cancer and its distinct clinical significance among molecular-histologic subtypes
4个月前
已完结
Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and Prognosis of Primary Central Nervous System Lymphoma
4个月前
已完结
Optimizing treatment for HER2-positive HR-positive breast cancer
5个月前
已完结
Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents
5个月前
已完结
皖公网安备34019202002308
